Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer.

PURPOSE This analysis was performed to clarify the relationship of young age at diagnosis to the pathologic features of the tumor and prognosis in patients with early-stage breast cancer. PATIENTS AND METHODS We retrospectively analyzed data from 1,398 patients with American Joint Committee on Cancer Staging stage I or II breast cancer treated by breast-conserving therapy between 1968 and 1985. One hundred seven patients were younger than 35 years at the time of diagnosis. The median follow-up duration for the 1,032 survivors was 99 months. RESULTS Patients younger than 35 years had a significantly higher overall recurrence rate (P = .002), as well as a greater risk for developing distant metastases (P = .03), when compared with older patients. The cancers in younger patients more commonly showed factors associated with a worse prognosis (including grade 3 histology, lymphatic vessel invasion [LVI], necrosis, and estrogen receptor [ER] negativity) as compared with older patients. In a proportional hazards model that included clinical and treatment-related variables, as well as these pathologic features, age younger than 35 years remained a significant predictor for time to recurrence (relative risk [RR], 1.70), time to distant failure (RR, 1.60), and overall mortality (RR, 1.50). CONCLUSION Breast cancer patients younger than 35 years have a worse prognosis than older patients. This difference is only partially explained by a higher frequency of adverse pathologic factors seen in younger patients.

[1]  B. Asselain,et al.  Age as prognostic factor in premenopausal breast carcinoma , 1993, The Lancet.

[2]  C. Redmond,et al.  Pathologic findings from the national surgical adjuvant breast project protocol B‐06 10‐year pathologic and clinical prognostic discriminants , 1993, Cancer.

[3]  R. Epstein.  Analysis of natural history of breast cancer in young women , 1992, The Lancet.

[4]  D. Anderson.  Familial versus sporadic breast cancer , 1992, Cancer.

[5]  M. Mazumdar,et al.  Infiltrating breast carcinoma in patients age 30 years and younger: long term outcome for life, relapse, and second primary tumors. , 1992, International journal of radiation oncology, biology, physics.

[6]  S J Schnitt,et al.  The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. , 1991, Annals of surgery.

[7]  D. Schultz,et al.  The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. , 1991, International journal of radiation oncology, biology, physics.

[8]  M. King,et al.  Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.

[9]  H. Kooy,et al.  Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  C. Bressac,et al.  Why are local recurrences after breast-conserving therapy more frequent in younger patients? , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  R. Gelber,et al.  Improved methodology for analyzing local and distant recurrence. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Vilcoq,et al.  Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. , 1989, International journal of radiation oncology, biology, physics.

[13]  W. Gerald,et al.  Conservative surgery and radiation therapy in breast carcinoma: local recurrence and prognostic implications. , 1989, International journal of radiation oncology, biology, physics.

[14]  S. Schnitt,et al.  The predictors of distant relapse following conservative surgery and radiotherapy for early breast cancer are similar to those following mastectomy. , 1989, International journal of radiation oncology, biology, physics.

[15]  D. Schultz,et al.  Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer. , 1987, International journal of radiation oncology, biology, physics.

[16]  E. Montague,et al.  Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy. , 1988, International journal of radiation oncology, biology, physics.

[17]  J. Peterse,et al.  The impact of tumor size and histology on local control after breast-conserving therapy. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  S Friedman,et al.  The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Kurtz,et al.  Conservation treatment of early breast cancer: long term results and complications. , 1987, International journal of radiation oncology, biology, physics.

[20]  I Persson,et al.  The relation between survival and age at diagnosis in breast cancer. , 1986, The New England journal of medicine.

[21]  H. Høst,et al.  Age as a prognostic factor in breast cancer , 1986, Cancer.

[22]  S. Paik,et al.  Pathologic findings from the national surgical adjuvant breast project (protocol 6) I. Intraductal carcinoma (DCIS) , 1986, Cancer.

[23]  S. Schnitt,et al.  Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. , 1985, International journal of radiation oncology, biology, physics.

[24]  P. Rosen,et al.  Breast carcinoma at the extremes of age: A comparison of patients younger than 35 years and older than 75 years , 1985, Journal of surgical oncology.

[25]  E. Baráth,et al.  Fundamentals of Biostatistics. , 1992 .

[26]  J. Harris,et al.  Primary radiation therapy for early breast cancer: the experience at The Joint Center for Radiation Therapy. , 1981, International journal of radiation oncology, biology, physics.

[27]  C. Redmond,et al.  Pathologic findings from the national surgical adjuvant breast project (protocol no. 4) vi. discriminants for five‐year treatment failure , 1980, Cancer.

[28]  G K Svensson,et al.  A modified three-field technique for breast treatment. , 1977, International journal of radiation oncology, biology, physics.

[29]  B. Fisher,et al.  The pathology of invasive breast cancer A Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4) , 1975, Cancer.

[30]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .

[31]  D. Cox.  Regression Models and Life-Tables , 1972 .

[32]  W. Donegan,et al.  A biostatistical study of locally recurrent breast carcinoma. , 1966, Surgery, gynecology & obstetrics.

[33]  C. Haagensen,et al.  Age and Menstrual Status as Prognostic Factors in Carcinoma of the Breast , 1963, Annals of surgery.

[34]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[35]  W. Rienhoff,et al.  Results of Operations at the Johns Hopkins Hospital for Cancer of the Breast: Performed at the Johns Hopkins Hospital from 1889 to 1931. , 1932, Annals of surgery.

[36]  W. Halsted,et al.  I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. , 1894, Annals of surgery.